Consolidated Statements of Operations (USD $)	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012
Revenues	$ 14,668,455	$ 14,329,889
Cost of revenues	12,947,217	11,949,124
Gross profit	1,721,238	2,380,765
Research and development	16,917,396	10,451,070
Selling, general, and administrative	21,612,793	22,315,346
Operating Expenses	38,530,189	32,766,416
Operating loss	(36,808,951)	(30,385,651)
Other income (expense):
Other (expense) income, net	(1,614,858)	(4,314,228)
Interest expense	(281,421)	(1,576,975)
Nonoperating Income (Expense), Total	(1,896,279)	(5,891,203)
Loss from operations before provision for income taxes and noncontrolling interests	(38,705,230)	(36,276,854)
Provision (benefit) for income taxes	780,104	(175,533)
Net loss from continuing operations	(39,485,334)	(36,101,321)
Loss from discontinued operations - net	0	(30,267,990)
Net loss	(39,485,334)	(66,369,311)
Less - loss from continuing operations attributable to noncontrolling interests	(504,090)	(287,181)
Less - loss from discontinued operations attributable to noncontrolling interests	0	(12,312,646)
Net loss attributable to NeoStem, Inc.	(38,981,244)	(53,769,484)
Warrant inducements	0	(1,012,819)
Preferred dividends		(528,023)
Amounts Attributable to NeoStem, Inc. common shareholders:
Loss from continuing operations	(38,981,244)	(35,814,140)
Loss from discontinued operations - net of taxes	0	(17,955,344)
Warrant inducements	0	(1,012,819)
Preferred dividends	0	(528,023)
Net loss attributable to NeoStem, Inc. common stockholders	$ (38,981,244)	$ (55,310,326)
Basic and diluted (loss) per share attributable to:
Continuing operations	$ (1.90)	$ (2.59)
Discontinued operations	$ 0.00	$ (1.30)
NeoStem, Inc. common stockholders	$ (1.90)	$ (4.00)
Weighted average common shares outstanding	20,495,771	13,841,997